Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Consumer branding is another world
- What do the following brands have in common?
- US brand leaders in 1925 and 1985
- FMCG Longevity of brands
- A little known table
- Product brands with staying power
- But this is how we think about it
- Pharma brands vs. FMCG brands - brand building
- Differences in attitude to brand building
- Why the difference?
- The product attribute trap
- Brand theory can be confusing
- Few pharma people really understand the basics
- Brand identity vs. brand image
- Fewer understand the latest thinking
- The neuro-cultural view of brands
- Brand function hierarchy
- Operating within changing markets
- Put simply
- Brand equity value creation in pharma
- Future of branding in pharmaceutical industry (1)
- Brand architecture
- How does this relate to pharma?
- Pharmaceutical portfolio's
- Kapferer theory
- Kapferer brand architecture theory
- Pharma equivalents?
- Pharmaceutical brand strategy hierarchy
- One additional pharma brand extension strategy
- Aaker brand driver roles
- Aaker brand architecture
- Aaker corporate brand strategy examples
- What can we learn from the consumer world?
- What can we learn?
- Future of branding in pharmaceutical industry (2)
- Brand management needs to add value
- The pharmaceutical industry's value curve
- How does consumer brand management advance?
- Brand management evolving paradigm
- What do we need to do?
- Pharmaceutical brand logic
- What we need to do - pharmaceutical brand logic
- Thank you
Topics Covered
- How has consumer branding developed and what are the differences between it and pharmaceutical branding
- Established consumer brand architecture and how to apply it to pharmaceuticals
- Kapferer and Aaker theory and how it can be applied
- The future for branding within pharmaceuticals
Talk Citation
Moss, G.D. (2009, January 28). The future of branding within the pharmaceutical industry [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/UJNH8098.Export Citation (RIS)
Publication History
Financial Disclosures
- Mr. Giles D. Moss has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.